Board approves preferential issue of shares and warrants worth about Rs 33 crore

Board & Shareholder Meetings View source PDF

SHIVALIK · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+9.9%1-day move

₹242.00

prior close

₹242.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

—+1.2+1.2+4.9+9.9—————————

Up moveDown movePending

AI summary

Board approved preferential issue of up to 3,72,000 equity shares at Rs 250 each (about Rs 9.3 crore) to 5 public investors, and up to 9,48,000 fully convertible warrants at Rs 250 each (about Rs 23.7 crore) to promoter Growel Remedies and public entities Bishnoi Exports and Ginnerup Capital. Total potential raise about Rs 33 crore. EGM scheduled for Aug 20, 2026 for shareholder approval.

Likely market impact

Equity dilution of up to Rs 33 crore. Promoter participation signals confidence. Subject to shareholder approval at EGM on Aug 20, 2026.